Stay updated on Pembrolizumab Combo in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Lung Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the pembrolizumab combination study is now available instead of an error page. It presents the study design, participant criteria, measured outcomes, publications, and supporting documents.
    Difference
    100%
    Check dated 2026-11-11T02:20:47.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error rather than study details.
    Difference
    0.2%
    Check dated 2026-11-04T01:12:54.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    An NIH-wide notice about the terminology transition appears above the 403 error page. The site revision label also advances from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T01:10:37.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.7.1 instead of v3.7.0. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T01:14:41.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record content, with a minimal header and a Home link indicating restricted access. This reflects an access restriction rather than a substantive data update.
    Difference
    25%
    Check dated 2026-09-23T01:13:00.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.6 to v3.7.0 on the page, indicating an update to the site's template or CMS without changing the study details.
    Difference
    0.0%
    Check dated 2026-09-16T00:16:15.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Lung Cancer Clinical Trial page.